Lower Cerebrospinal Fluid Amyloid-β42Predicts Sooner Time to Antipsychotic Use in Alzheimer's Disease

Joshua G. Cahan*, Robert Vassar, Borna Bonakdarpour

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Lower Cerebrospinal Fluid Amyloid-β42Predicts Sooner Time to Antipsychotic Use in Alzheimer's Disease'. Together they form a unique fingerprint.

Keyphrases

Neuroscience